ribomedicine.bsky.social
Research team of Tom Roberts at the University of Oxford, Department of Paediatrics, and Institute of Developmental and Regenerative Medicine. Our work focuses on RNA-based medicine and neuromuscular disorders. https://www.idrm.ox.ac.uk/research/neurology
👤 Joined on 19 November 2024
Followers
Following
Total Posts
@ribomedicine.bsky.socialNew #MolTherMethClinDev paper from @RueggLab: AAV capsids target muscle resident cells with different efficiencies - a comparative study between AAV8, AAVMYO and AAVMYO2. #MyoBlue tinyurl.com/mvk3htjw
Show PostHappy to be a part of another great collaboration with @JimDowling for this new @MolTherapy #MTNA paper: microRNA-133a as an indicator of disease progression and treatment response in X-linked myotubular myopathy. #Myoblue. 1/n tinyurl.com/yc5bdbfe
Show PostCongratulations to the Roberts Group on their recent study, published in Molecular Therapy: Nucleic Acids, challenging the therapeutic potential of a mechanism previously thought to upregulate protein expression in specific genes. @ribomedicine.bsky.social @oxfordpaediatrics.bsky.social
Show PostCongrats to #StainierLab and colleagues for this interesting new @Nature manuscript: Transcriptional adaptation upregulates utrophin in Duchenne muscular dystrophy. #DMD #MyoBlue tinyurl.com/4ky93z67
Show PostGood to hear that my university (Leeds) is completely withdrawing from X. I hope others follow suit.
Show Post